by Vora Corporate Finance | Jul 4, 2024 | Insights, Private Equity & IPO
Transaction: Quadria Capital, one of Asia’s largest healthcare-focused private equity firm invested INR 850 Crores in a series F funding round of NephroPlus, valuing the company at more than Rs. 2000 Crores. Through this transaction, Quadria acquires significant...
by Vora Corporate Finance | May 20, 2021 | Financial Advisory, Insights, Private Equity & IPO
Transaction: Creador sold its stake in Ahmedabad based Corona Remedies to PE fund ChrysCapital. ChrysCapital paid Rs.6.7 billion ($90 million) for a 30% stake, of which 20% came from Creador and 10% from the promoter group. The deal values Corona Remedies at around...
by Karan Vora | Jul 4, 2020 | Financial Advisory, Insights, Merger & Acquisitions, Private Equity & IPO
Valuation certificates for compliance are required under Companies Act 2013, Income Tax Act, SEBI Regulations and FEMA regulations in India. While earlier the Valuation service was primarily provided by the Chartered Accountants (CA) and Merchant Bankers (MB)....
by Karan Vora | Jan 17, 2020 | Insights
This article was published by Journal of Chartered Accountants Association in the issue of October 2019. Link to Journal of Chartered Accountants Association, Ahmedabad: https://www.caa-ahm.org/JournalDetail.php Link to published...
by Karan Vora | Jan 11, 2020 | Insights
Indian Economic activity remained weak in the month of August as GDP slumped to 5.0 percent in Q1 2019-20. Monetary policy committee of RBI maintained the accommodative stance and slashed the repo rate by 35 basis points from 5.75% to 5.40% in July 2019. The rate was...
